Stock Price
726.00
Daily Change
7.40 1.03%
Monthly
6.20%
Yearly
13.23%
Q1 Forecast
686.63

argenx SE reported $288.02M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
AstraZeneca USD 4.96B 127M Jun/2025
Galapagos EUR -158.71M 177.84M Mar/2025
Genmab DKK 477M 101M Sep/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Qiagen NV USD 193.17M 15.81M Sep/2025
UCB EUR 1.03B 334M Jun/2025